ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany
· Delayed Price · Currency is EUR 63.50
0.00 (0.00%)
At close: Mar 9, 2026
ANI Pharmaceuticals Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,333 | 1,405 | 1,043 | 952 | 614 | 678 | Upgrade
|
| Market Cap Growth | 19.71% | 34.81% | 9.52% | 55.11% | -9.53% | 138.20% | Upgrade
|
| Enterprise Value | 1,620 | 1,712 | 1,529 | 1,063 | 855 | 850 | Upgrade
|
| Last Close Price | 63.50 | 68.00 | 51.00 | 48.60 | 37.60 | 40.80 | Upgrade
|
| PE Ratio | 22.29 | 23.50 | - | 68.00 | - | - | Upgrade
|
| PS Ratio | 1.77 | 1.87 | 1.76 | 2.16 | 2.07 | 3.57 | Upgrade
|
| PB Ratio | 2.89 | 3.05 | 2.52 | 2.30 | 1.94 | 2.15 | Upgrade
|
| P/TBV Ratio | - | - | - | 5.38 | 19.39 | 64.94 | Upgrade
|
| P/FCF Ratio | 9.13 | 9.63 | 22.59 | 9.56 | - | 1008.43 | Upgrade
|
| P/OCF Ratio | 8.45 | 8.91 | 16.86 | 8.85 | - | 232.23 | Upgrade
|
| EV/Sales Ratio | 2.13 | 2.28 | 2.58 | 2.41 | 2.89 | 4.47 | Upgrade
|
| EV/EBITDA Ratio | 10.54 | 11.50 | 17.98 | 10.75 | 26.93 | 50.64 | Upgrade
|
| EV/EBIT Ratio | 22.55 | 24.12 | 77.92 | 23.73 | - | - | Upgrade
|
| EV/FCF Ratio | 11.10 | 11.73 | 33.14 | 10.67 | - | 1263.31 | Upgrade
|
| Debt / Equity Ratio | 1.16 | 1.16 | 1.46 | 0.62 | 0.85 | 0.80 | Upgrade
|
| Debt / EBITDA Ratio | 3.52 | 3.52 | 7.09 | 2.61 | 8.26 | 15.06 | Upgrade
|
| Debt / FCF Ratio | 3.67 | 3.67 | 13.06 | 2.60 | - | 375.65 | Upgrade
|
| Net Debt / Equity Ratio | 0.62 | 0.62 | 1.10 | 0.14 | 0.71 | 0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.91 | 1.91 | 5.37 | 0.59 | 7.07 | 9.80 | Upgrade
|
| Net Debt / FCF Ratio | 1.95 | 1.95 | 9.90 | 0.59 | -5.98 | 244.54 | Upgrade
|
| Asset Turnover | 0.65 | 0.65 | 0.56 | 0.59 | 0.41 | 0.35 | Upgrade
|
| Inventory Turnover | 2.44 | 2.44 | 2.02 | 1.68 | 1.48 | 1.41 | Upgrade
|
| Quick Ratio | 2.07 | 2.07 | 1.92 | 2.63 | 2.15 | 2.61 | Upgrade
|
| Current Ratio | 2.71 | 2.71 | 2.72 | 3.57 | 3.46 | 3.68 | Upgrade
|
| Return on Equity (ROE) | 16.16% | 16.16% | -4.18% | 4.72% | -13.74% | -15.37% | Upgrade
|
| Return on Assets (ROA) | 3.82% | 3.82% | 1.16% | 3.72% | -2.10% | -2.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.83% | 7.67% | 2.85% | 8.51% | -4.58% | -6.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 7.20% | 1.90% | 6.50% | -3.90% | -4.10% | Upgrade
|
| Earnings Yield | 4.49% | 4.75% | -1.72% | 1.79% | -7.30% | -5.52% | Upgrade
|
| FCF Yield | 10.95% | 10.39% | 4.43% | 10.46% | -6.11% | 0.10% | Upgrade
|
| Payout Ratio | 1.48% | 1.48% | - | 8.65% | - | - | Upgrade
|
| Buyback Yield / Dilution | -9.89% | -9.89% | -6.18% | -11.89% | -29.09% | -5.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.